Deep Semi Supervised Generative Learning for Automated PD-L1 Tumor Cell Scoring on NSCLC Tissue Needle Biopsies
Ansh Kapil, Armin Meier, Aleksandra Zuraw, Keith Steele, Marlon, Rebelatto, G\"unter Schmidt, Nicolas Brieu

TL;DR
This paper introduces a deep semi-supervised learning method for automated, objective PD-L1 tumor cell scoring in NSCLC biopsies, reducing variability and manual effort compared to traditional visual assessments.
Contribution
It presents the first automated PD-L1 scoring system for NSCLC biopsies using semi-supervised deep learning, improving consistency and reducing manual annotation needs.
Findings
Automated scoring matches visual pathologist assessments.
Method ensures repeatability and objectivity.
Semi-supervised approach reduces annotation requirements.
Abstract
The level of PD-L1 expression in immunohistochemistry (IHC) assays is a key biomarker for the identification of Non-Small-Cell-Lung-Cancer (NSCLC) patients that may respond to anti PD-1/PD-L1 treatments. The quantification of PD-L1 expression currently includes the visual estimation of a Tumor Cell (TC) score by a pathologist and consists of evaluating the ratio of PD-L1 positive and PD-L1 negative tumor cells. Known challenges like differences in positivity estimation around clinically relevant cut-offs and sub-optimal quality of samples makes visual scoring tedious and subjective, yielding a scoring variability between pathologists. In this work, we propose a novel deep learning solution that enables the first automated and objective scoring of PD-L1 expression in late stage NSCLC needle biopsies. To account for the low amount of tissue available in biopsy images and to restrict the…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
